Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00289549
Status:
COMPLETED
Last Update Posted:
2012-02-08
First Post:
2006-02-08
Brief Title:
Study of Forodesine Hydrochloride in Patients With Advanced Fludarabine-refractory Chronic Lymphocytic Leukemia CLL
Sponsor:
BioCryst Pharmaceuticals
Organization:
BioCryst Pharmaceuticals
Organization Data
Organization:
BioCryst Pharmaceuticals
Class:
INDUSTRY
Study ID:
BCX1777-Bo-05-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioCryst Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None